Low pressure hyperbaric therapy shown effective in helping metabolic syndrome and reducing cardiac risks
Posted on Monday, May 8th, 2017
A new study in the Journal of atherosclerosis and thrombosis published this year shows that low pressure hyperbaric oxygen therapy can be a very effective tool for helping those suffering from metabolic syndrome.
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.
This study looked at only 1.25 ATA (low pressure hyperbarics) and found that this dosage was effective enough to produce a lowering of blood sugars, blood pressure, total cholesterol, and insulin. Many other positive benefits were noted, click here to read the study in full.